Abstract
Background Post-COVID conditions (PCC) present clinicians with significant challenges due to their variable presentation.
Objective To characterize patterns of PCC diagnosis in generalist primary care settings.
Design Retrospective observational study
Setting 519 primary care clinics around the United States who were in the American Family Cohort registry between October 1, 2021 and November 1, 2023.
Patients 6,116 with diagnostic code for PCC; 5,020 with PCC and COVID-19
Measurements Time between COVID-19 and PCC (U09.9) diagnostic codes; count of patients with PCC diagnostic codes per clinician; patient-specific probability of PCC diagnostic code estimated by a tree-based machine learning model trained on clinician and specific practice visited, patient demographics, and other diagnoses; performance of a natural language classifier trained on notes from 5,000 patients annotated by two physicians to indicate probable PCC.
Results Of patients with diagnostic codes for PCC and COVID-19, 43.0% were diagnosed with PCC less than 4 weeks after initial recorded COVID-19 diagnostic code. Six clinicians (out of 3,845 total) made 15.4% of all PCC diagnoses. The high-performing (F1: 0.98) tree-based model showed that patient demographics, practice visited, clinician visited, and calendar date of visit were more predictive of PCC diagnostic code than any symptom. Inter-rater agreement on PCC diagnosis was moderate (Cohen’s kappa: 0.60), and performance of the natural language classifiers was poor (best F1: 0.54).
Limitations Cannot validate date of COVID-19 diagnosis, as it may not reflect when disease began and could have been coded retrospectively. Few options for medically focused language models.
Conclusion We identified multiple sources of heterogeneity in the documentation of PCC diagnostic codes in primary care practices after introduction of ICD-10 codes for PCC, which has created challenges for public health surveillance.
Funding Source US CDC
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the United States Centers for Disease Control and Prevention.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was exempted from human subjects review by the IRB of the American Academy of Family Physicians.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data may be available for IRB-approved research subject to approval of the American Board of Family Medicine Research Governance Board.
